Call for Abstract

42nd Euro-Global Summit on Cancer Therapy & Radiation Oncology, will be organized around the theme “Advancing Novel Approaches in Diagnosis and Cancer Therapies”

Euro Cancer 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Cancer 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 2-1Surgical Therapy
  • Track 2-2Photodynamic Therapy
  • Track 2-3Hormonal Therapy
  • Track 2-4Palliative Therapy
  • Track 2-5Adjuvant Therapy
  • Track 3-1Tumor Biology
  • Track 3-2Cancer Epigenetics
  • Track 3-3Oncogenes & Proto-oncogenes
  • Track 3-4Tumour Suppressor Genes
  • Track 4-1Cancer Stem Cells
  • Track 4-2Stem Cell Transplantation
  • Track 4-3Bone Marrow Transplantation
  • Track 4-4CSCs and Cancer Treatment
  • Track 5-1Breast Cancer
  • Track 5-2Eye Cancer
  • Track 5-3Blood Cancer
  • Track 5-4Liver Cancer
  • Track 5-5Leukaemia
  • Track 5-6Lymphoma
  • Track 5-7Lung Cancer
  • Track 5-8Prostate Cancer
  • Track 5-9Bone Cancer
  • Track 5-10Brain Cancer
  • Track 5-11Vulvar Cancer
  • Track 5-12Ovarian Cancer
  • Track 5-13Uterus Cancer
  • Track 5-14Gynaecologic Cancers -Cervical Cancer
  • Track 5-15Gastrointestinal Cancer
  • Track 5-16Skin Cancer
  • Track 6-1Diagnostic Biomarkers
  • Track 6-2Pharmacodynamics and pharmacokinetics
  • Track 6-3Prognosis, Screening and treatment predictions
  • Track 6-4Risk assessment, Diagnosis
  • Track 6-5Biomarkers in Medicine
  • Track 6-6Biomarkers in Cancer Research
  • Track 6-7Companion Biomarker
  • Track 6-8Predictive & Prognostic Biomarkers
  • Track 6-9Tumour Suppressors Biomarkers
  • Track 6-10Molecular cancer biomarkers
  • Track 7-1CAR T-Cell Therapy
  • Track 7-2Oncolytic viral therapies
  • Track 7-3Gene therapy
  • Track 7-4Adoptive T-Cell transfer
  • Track 7-5Oncoviruses
  • Track 7-6Therapeutic Cancer Vaccines
  • Track 7-7HPV & Hepatitis B vaccine
  • Track 7-8Personalised Cancer Vaccines
  • Track 7-9Clinical Trails
  • Track 8-1Cancer Microenvironment
  • Track 8-2Chemo Drugs
  • Track 8-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 8-4Vector/Host Interaction
  • Track 8-5New Nanomaterials
  • Track 8-6Imaging and Theranostics
  • Track 8-7Early Diagnosis and Imaging
  • Track 8-8Advances in Nanotechnology
  • Track 9-1Clinical Toxicology
  • Track 9-2Pharmacokinetics
  • Track 9-3Pharmacodynamics
  • Track 9-4Drug interactions
  • Track 9-5Cancer Drug Targets
  • Track 9-6Molecular Carcinogenesis
  • Track 9-7Biochemical Pharmacology
  • Track 9-8Clinical Pharmacology
  • Track 10-1Treatment strategies
  • Track 10-2Adverse effects
  • Track 10-3Limitations
  • Track 10-4Cancer Therapeutics, Novel and experimental approaches
  • Track 11-1Medical Oncology
  • Track 11-2Uro-Oncology
  • Track 11-3Neuro-oncology
  • Track 11-4Clinical Oncology
  • Track 11-5Hematologic Oncology
  • Track 11-6Paediatric Oncology
  • Track 11-7Gynaecologic Oncology
  • Track 11-8Radiation Oncology-Radiation Therapies & Techniques, Medical Imaging, Radiobiology, Nuclear Medicine, Radiation Physics, Curative Radiation Therapy
  • Track 11-9Surgical Oncology-Surgical Techniques, General & Gynaec-onco surgeries, Radical procedures, Surgical Biopsies, Reconstructive Surgery
  • Track 11-10Dermato Oncology
  • Track 12-1Physiology & Cancer History
  • Track 12-2Identifying Risk Factors
  • Track 12-3Cancer Genomics & Biologic Factors
  • Track 12-4Targeted Agents & Conventional Treatment
  • Track 12-5New Genotyping Technologies
  • Track 13-1Cancer Etiology
  • Track 13-2Health Disparities
  • Track 13-3Genetic and molecular epidemiology
  • Track 13-4Environmental Carcinogens
  • Track 13-5Gene-Environment Interactions
  • Track 13-6Cancer Risk Prediction
  • Track 14-1Radiation Therapy
  • Track 14-2Immunotherapy
  • Track 14-3Targeted Cancer Therapies and Treatment
  • Track 14-4Stem Cell Therapy
  • Track 14-5Cancer Surgery
  • Track 14-6Hormonal Therapy
  • Track 14-7Precision Medicine
  • Track 14-8Palliative Care & Treatment
  • Track 15-1Host-Tumour Relation
  • Track 15-2Cancer Immunosurveillance and Immunoediting
  • Track 15-3Clinical Cancer immunology
  • Track 15-4Cancer Antigens & Vaccines
  • Track 15-5Cellular Immunotherapy
  • Track 15-6Antibody Therapy
  • Track 15-7Cytokine Therapy
  • Track 15-8Combination & Combinatorial Ablation and Immunotherapies
  • Track 16-1Patient Assessment & Education
  • Track 16-2Management & Palliative Care
  • Track 16-3Assessing Physical & Emotional Status
  • Track 16-4Treatment Plans
  • Track 16-5Symptom Management
  • Track 16-6Supportive Care
  • Track 16-7Direct Patient Care
  • Track 17-1Aromatherapy
  • Track 17-2Ayurveda
  • Track 17-3Reflexology
  • Track 17-4Art & Music Therapy
  • Track 17-5Homeopathic Medicines
  • Track 17-6Naturopathy
  • Track 17-7Anti-Cancer Agents in Medicinal Chemistry
  • Track 17-8Acupuncture